98%
921
2 minutes
20
With the power conversion efficiency of binary polymer solar cells dramatically improved, the thermal stability of the small-molecule acceptors raised the main concerns on the device operating stability. Here, to address this issue, thiophene-dicarboxylate spacer tethered small-molecule acceptors are designed, and their molecular geometries are further regulated via the thiophene-core isomerism engineering, affording dimeric TDY-α with a 2, 5-substitution and TDY-β with 3, 4-substitution on the core. It shows that TDY-α processes a higher glass transition temperature, better crystallinity relative to its individual small-molecule acceptor segment and isomeric counterpart of TDY-β, and a more stable morphology with the polymer donor. As a result, the TDY-α based device delivers a higher device efficiency of 18.1%, and most important, achieves an extrapolated lifetime of about 35000 hours that retaining 80% of their initial efficiency. Our result suggests that with proper geometry design, the tethered small-molecule acceptors can achieve both high device efficiency and operating stability.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203300 | PMC |
http://dx.doi.org/10.1038/s41467-023-38673-5 | DOI Listing |
Acc Chem Res
September 2025
Department of Pharmaceutical Chemistry and Small Molecule Discovery Center, University of California, San Francisco 94158, United States.
ConspectusProtein-protein interactions (PPIs) play a key role in homeostasis and are often dysregulated in disease. PPIs were traditionally considered "undruggable" due to their flat surfaces and disordered domains. Recently, the identification of PPI stabilizers, or molecular glues (MGs), compounds that bind cooperatively to PPI interfaces, has provided a new direction for the field.
View Article and Find Full Text PDFRes Sq
August 2025
Translational Cancer Medicine Research Program, University of Helsinki, Finland.
Kaposi's sarcoma herpesvirus (KSHV) establishes lifelong oncogenic infection in lymphatic endothelial cells (LECs) by ensuring episomal maintenance of its genome via the viral protein LANA. Efficient viral genome maintenance typically involves host DNA replication and episome tethering, but the extent of cell-type-specific regulation remains unclear. Here, we identify that KSHV hijacks the pioneering function of the endothelial-specific transcription factor SOX18 to facilitate persistence of viral episomes.
View Article and Find Full Text PDFBioorg Chem
August 2025
Department of Organic and Medicinal Chemistry, CSIR-Indian Institute of Chemical Biology (CSIR-IICB), 4, Raja S. C. Mullick Road, Jadavpur, Kolkata, INDIA.; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, INDIA.. Electronic address:
BET proteins contain two tandem bromodomains (BD1 and BD2) that bind histone acetyl-lysine residues that can be targeted with small molecule inhibitors such as IBET-762, which bears a triazolo benzodiazepine core. Here, we report the consequences of substituting the pendant chlorobenzene moiety of IBET-762. Substitution with larger ring structures diminishes bromodomain binding, and even subtle changes on the phenyl ring significantly impact affinity.
View Article and Find Full Text PDFMetallomics
July 2025
Department of Chemistry, Colgate University, Hamilton, NY 13346, United States.
Zinc(II) ions play manifold roles in human health; dysregulation of zinc homeostasis has been implicated in a number of diseases and pathological conditions. Because zinc(II) is spectroscopically silent, it cannot be detected directly by conventional fluorescence microscopy. As a result, investigators seeking to image zinc(II) in biological systems frequently turn to small-molecule fluorescent sensors that selectively respond to the presence of the ion.
View Article and Find Full Text PDFEur J Med Chem
October 2025
Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, 264117, China. Electronic address:
Histone lysine-specific demethylase 5B (KDM5B) is frequently overexpressed in a wide range of tumors and is regarded as a promising target for drug development. Current drugs targeting KDM5B are primarily small-molecule inhibitors, which suffer from limitations such as poor selectivity and insufficient pharmacological efficacy. Targeted protein degradation (TPD) technology as an emerging drug development strategy has received extensive attention in recent years, that enables the catalytic elimination of the entire protein of interest, thereby disrupting both the enzymatic and non-enzymatic functions.
View Article and Find Full Text PDF